The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

19 Jan 2018 07:00

RNS Number : 3298C
Blancco Technology Group PLC
19 January 2018
 

Friday 19 January 2018

BLANCCO TECHNOLOGY GROUP PLC

("Blancco" the "Company" or the "Group")

TRADING UPDATE AND NOTICE OF RESULTS

Blancco Technology Group PLC (AIM: BLTG, "Blancco"), a leading global provider of mobile device diagnostics and secure data erasure solutions, today issues this trading update for the six months to 31 December 2017, in advance of its half yearly results which will be announced on 20 March 2018.

During the six months to the end of December 2017 significant management time and effort was focused on the immediate priorities required to place Blancco on the best operational and financial footing following the resignation of the CEO and the review of the accounting for contracts and financial controls.

Revenue in the first half of the current financial year was marginally behind that of the same period last year, but we expect trading to grow during the second half leading to positive full year revenue growth. The impact of currency has been slightly adverse following the strengthening of Sterling.

Results for the six months to 31 December 2016 included a number of non-repeating volume sales deals, where revenue was recognised up front on the sale of software covering multiple future years. Several of these replaced deals previously contracted and recognised over time on a monthly basis. These were not due for renewal during December 2017 impacting Blancco's comparative year on year revenue and the contract renewal rate. New client contracts won during the current period did not fully mitigate the impact of last year's non-repeating deals.

Overall the Group's Erasure division saw a decline in year on year sales due to the non-renewal of multiyear End of Life Erasure contracts as mentioned above. Mobile Erasure saw a substantial growth rate as we secured numerous new clients.

The Group's Mobile Diagnostics division, remained flat, in line with management's expectations for the first half.

As we expected, Adjusted Operating Profit (AOP) was lower than in the prior year, due to the lower revenue and the significant SG&A costs taken on during Q2 and Q3 of the prior year flowing through the first half this year. Adjusted Operating Profit margin percentage was lower than full year guidance, but was better than our first half expectations, following the reorganisation and cost savings made between September and December 2017.

We now expect full year revenues to be towards the lower end of our guidance range while AOP and cashflow remain in line.

During the period we also negotiated the sale of our Mexican legal entity, which will become a distributor of Blancco products in the LATAM region, consequently we have reclassified the results of the Mexican business as discontinued and treated them appropriately in the current and prior financial periods. We believe that this structure will benefit both parties to the transaction and promote the growth of Blancco services in the region.

Payments related to the restructuring of the management team and a legacy payment relating to prior year M&A have reduced cash balances since the financial year end, however, the Group's operating cash flow before interest and tax remains positive.

The CEO recruitment process is progressing well and we will update the market at the appropriate time.

The Board is confident that we have considerably improved the functioning of the business, which stands Blancco in much better stead for the new CEO to execute a sustainable growth strategy, allowing the Group to leverage its market leading position and take advantage of growing demand.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/ 2014.

Blancco Technology Group Plc +44 (0) 20 3657 7000

Simon Herrick, Interim Chief Executive Officer & Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Broker) +44 (0) 20 7418 8900

Edward Knight

Nick Prowting

Panmure Gordon (UK) Limited (Joint Broker) +44 (0) 20 7886 2500

Dominic Morley, Corporate Finance

Charles Leigh Pemberton, Corporate Broking

Tulchan Communications +44 (0) 20 7353 4200

Tom Murray

Matt Low

About Blancco

Blancco Technology Group is a leading global provider of mobile device diagnostics and secure data erasure solutions. For more information, please visit www.blanccotechnologygroup.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBGDBLUBBGII
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Blancco Technology Group plc
7th Nov 202311:01 amRNSNotification of Major Holdings
2nd Nov 20237:00 amRNSNotice of Closure of the Offer
23rd Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
20th Oct 202312:16 pmRNSCompulsory acquisition procedure
20th Oct 20237:00 amRNSCompulsory Acquisition Procedure
19th Oct 20233:30 pmRNSProposed Cancellation of Shares to Trading on AIM
19th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
18th Oct 20232:59 pmRNSAcceptance Level Update
18th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
18th Oct 20237:00 amRNSShare Allotment, TVR and Directors' Dealings
17th Oct 202311:14 amRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC Amend
16th Oct 20233:24 pmRNSForm 8.3 - Blancco Technology Group Plc
16th Oct 20231:58 pmBUSForm 8.3 - Blancco Technology Group plc
16th Oct 20231:25 pmPRNForm 8.3 - Blancco Technology Group Plc
16th Oct 202312:16 pmRNSForm 8.3 - Blancco Technology Group PLC
16th Oct 202312:13 pmRNSForm 8.3 - Blancco Technology Group plc
16th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
16th Oct 202311:49 amRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
16th Oct 20237:00 amRNSForm 8 (DD) - Blancco Technology Group plc
16th Oct 20237:00 amRNSOffer Declared Unconditional
13th Oct 20232:15 pmPRNForm 8.3 - Blancco Technology Group Plc
13th Oct 20231:22 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
13th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
13th Oct 202311:57 amBUSForm 8.3 - Offeree = Blancco Technology Group plc
13th Oct 202311:40 amRNSForm 8.3 - Blancco Technology Group PLC
13th Oct 202311:11 amRNSForm 8.3 - Blancco Technology Group PLC
13th Oct 20237:00 amRNSAcceptance Level Update
12th Oct 20232:39 pmPRNForm 8.3 - Blancco Technology Group Plc
12th Oct 20231:01 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
12th Oct 202312:53 pmRNSForm 8.3 - Blancco Technology Group PLC
12th Oct 202310:06 amRNSForm 8.3 - Blancco Technology Group PLC
12th Oct 20237:00 amRNSOffer Update
11th Oct 20232:15 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
11th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
11th Oct 202311:53 amRNSForm 8.3 - Blancco Technology Group PLC
10th Oct 20231:01 pmPRNForm 8.3 - Blancco Technology Group Plc
10th Oct 20237:00 amRNSNo Increase Statement and Acceptance Level Update
6th Oct 20236:18 pmRNSOffer Extension Announcement
6th Oct 20232:37 pmPRNForm 8.3 - Blancco Technology Group Plc
6th Oct 20237:00 amRNSAcceptance Level Update
5th Oct 20231:39 pmBUSForm 8.3 - Blancco Technology Group plc
5th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
5th Oct 20239:06 amRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
5th Oct 20237:00 amRNSAcceptance Level Update
5th Oct 20237:00 amRNSForm 8.3 - Blancco Technology Group PLC
4th Oct 20234:41 pmRNSNotification of Major Holdings
4th Oct 20231:40 pmEQSForm 8.3 - Apex Fundrock Limited : Re Blancco Technology Group Plc
4th Oct 20231:09 pmPRNForm 8.3 - Blancco Technology Group Plc
4th Oct 20237:00 amRNSAcceptance Level Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.